What Atai Beckley N.V.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 7,702,990 |
| Disposed | 0 | 0 |
| Net activity | +0 | +7,702,990 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Feilding-Mellen Cosmo | Director | Nov 05 | Grant / award · A | +7,702,990 | — | — | 7,702,990 |
| Apeiron Investment Group Ltd. | 10% owner | Sep 30 | Derivative Conversion · C | +2,367,200 | — | — | 53,412,414 |
| Apeiron Investment Group Ltd. | 10% owner | Aug 14 | Open-market buy · P | +8,675,799 | $2.19 | +$19M | 51,045,214 |
| Apeiron Investment Group Ltd. | 10% owner | Mar 24 | Open-market buy · P | +1,800,000 | $1.40 | +$2.52M | 42,369,415 |
| Kirpekar Sahil | Chief Business Officer | Mar 21 | Sale for tax withholding · S | −48,563 | $1.35 | −$65.6K | 115,636 |
| Johnson Anne Nagengast | Chief Financial Officer | Mar 21 | Sale for tax withholding · S | −33,545 | $1.35 | −$45.3K | 140,045 |
| Short Glenn Frank | Chief Scientific Officer | Mar 21 | Sale for tax withholding · S | −13,161 | $1.35 | −$17.8K | 42,333 |
| Rao Srinivas | See Remarks | Mar 21 | Sale for tax withholding · S | −75,418 | $1.35 | −$102K | 212,942 |
| Craig Kevin James | Chief Medical Officer | Mar 21 | Sale for tax withholding · S | −11,563 | $1.35 | −$15.6K | 8,437 |
| Kirpekar Sahil | Chief Business Officer | Mar 14 | Exercise / conversion · M | +100,000 | — | — | 164,199 |
| Johnson Anne Nagengast | Chief Financial Officer | Mar 14 | Exercise / conversion · M | +100,000 | — | — | 173,590 |
| Short Glenn Frank | Chief Scientific Officer | Mar 14 | Exercise / conversion · M | +32,500 | — | — | 55,494 |
| Rao Srinivas | See Remarks | Mar 14 | Exercise / conversion · M | +175,000 | — | — | 288,360 |
| Craig Kevin James | Chief Medical Officer | Mar 14 | Exercise / conversion · M | +20,000 | — | — | 20,000 |
| Apeiron Investment Group Ltd. | 10% owner | Feb 14 | Open-market buy · P | +10,835,718 | $2.10 | +$22.8M | 40,555,215 |
| Brand Florian | See Remarks | May 16 | Sale for tax withholding · S | −151,303 | $1.92 | −$291K | 328,697 |
| Kirpekar Sahil | Chief Business Officer | Apr 02 | Sale for tax withholding · S | −35,801 | $1.85 | −$66.2K | 64,199 |
| Johnson Anne Nagengast | Chief Financial Officer | Apr 02 | Sale for tax withholding · S | −27,410 | $1.85 | −$50.7K | 73,590 |
| Rao Srinivas | See Remarks | Apr 02 | Sale for tax withholding · S | −61,640 | $1.85 | −$114K | 113,360 |
| Brand Florian | See Remarks | Mar 14 | Exercise / conversion · M | +350,000 | — | — | 480,000 |
Loading...